What can be patented? In this article, we will discuss the types of inventions that can be patented and delve into the requirements for patentability. We’ll delve into the advantages of safeguarding your invention with a patent and provide an overview of how to obtain one in the US, from initial filing through completion.
Furthermore, understanding what cannot be patented is equally important. We will examine laws and regulations governing patent eligibility while identifying certain types of inventions that do not qualify for patents. This knowledge will help you identify potential alternatives to protect your innovative ideas.
In order to determine if your invention is eligible for a patent or not, our guide offers practical steps such as conducting thorough research on existing patents and the prior art, consulting with experts in your field, analyzing novelty and non-obviousness criteria, along with considering commercial potential. So let’s answer the question: what can be patented?
Table of Contents
- What Can Be Patented?
- Machines Eligible for Patent Protection
- Medicines and Chemical Compositions that are Patentable
- Processes Meeting Patentability Criteria
- Software Patents Challenges
- Software Patents vs Copyrights
- Obtaining International Software Patents
- What Can Be Patented: A Checklist
- United States Patent Laws
- Patentable Subject Matter
- Inventions That Cannot Be Patented
- Conclusion
What Can Be Patented?
The USPTO bestows patents on novel, utilitarian and creative ideas. These can include machines, medicines, computer programs, articles made by machines, compositions of matter such as chemicals or biogenetic materials, processes (an act or series of acts that produce an article), and even some software applications. However, laws of nature cannot be patented nor can any invention be deemed contrary to the public good.
Machines Eligible for Patent Protection
To be eligible for patent protection, a machine must be novel, have utility and not appear obvious to someone knowledgeable in the relevant field. Examples of patented machines range from simple devices like staplers to complex systems like autonomous vehicles.
Medicines and Chemical Compositions that are Patentable
New pharmaceutical drugs with therapeutic effects on humans or animals are eligible for patent protection if they demonstrate novelty and usefulness. Chemical compounds used in various industries such as agriculture or manufacturing may also receive patents if they meet these same requirements.
Vaccines developed using innovative techniques can potentially obtain a patent due to their unique composition of matter.
Processes Meeting Patentability Criteria
A process is defined as an act or series of acts that produce an article; this includes methods utilized within various fields including engineering design processes. This could involve creating new materials through specific treatments applied during production stages leading up to the final product assembly steps.
Processes can be patented if they are novel, useful, and non-obvious to a person skilled in the relevant field. Examples of patentable processes include manufacturing techniques for producing semiconductors or methods for purifying water.
To qualify for a patent, an invention must satisfy certain requirements.
Key Takeaway: What can be patented? The USPTO grants patents for new, useful, and nonobvious inventions such as machines, medicines, and processes. To be eligible for patent protection in the United States Patent system an invention must have novelty, utility and not be obvious to someone skilled in that field.
Software Patents Challenges
What can be patented? Can software be patented?
While software is eligible for both patent and copyright protection, obtaining a software patent can be quite challenging due to its complex nature. The intricate algorithms, data structures, and other technical facets of software inventions may prove difficult for those without specialized knowledge to comprehend. Furthermore, international patents for software can incur substantial costs and require extensive documentation.
Software Patents vs Copyrights
A key distinction between patents and copyrights lies in the type of protection they offer. While patents protect the underlying ideas or concepts behind an invention (such as a novel algorithm), copyrights safeguard the expression of those ideas (e.g., source code). As such, it’s essential for R&D managers, engineers, scientists, and commercialization teams to understand these differences when deciding on their intellectual property strategy.
In general terms:
- Patents: Grant exclusive rights to inventors over their inventions for a limited period (usually 20 years) in exchange for public disclosure of their work.
- Copyrights: Protect original works of authorship fixed in tangible mediums – including computer programs – against unauthorized copying or distribution without permission from copyright holders; typically lasts much longer than patent protection (life plus 70 years).
Obtaining International Software Patents
Filing international patent applications can be particularly daunting given varying requirements across different jurisdictions. For example: if you invent a new method for interchanging data between a smartphone and a thermostat internationally, there may be substantial costs involved in submitting international patent applications.
Additionally, navigating the legal landscape of each country’s patent office can prove to be time-consuming and resource-intensive.
To help overcome these challenges, consider the following steps:
- Consult with a Patent Professional: Engage an experienced patent attorney or agent who specializes in software patents to guide you through the process and ensure that your application meets all necessary requirements.
- Conduct Thorough Prior Art Searches: Before filing your application, perform comprehensive searches for existing patents and publications that could potentially affect your invention’s novelty or non-obviousness criteria – crucial factors when determining patent eligibility.
- Leverage International Filing Systems: Utilize global systems like the World Intellectual Property Organization’s Patent Cooperation Treaty (PCT) system to streamline filing processes across multiple countries. Meanwhile, you can defer national phase entry deadlines up to 30 months from the priority date, allowing more time for strategic decision-making regarding market entry plans.
Obtaining software patents can pose unique challenges due to their inherent complexity and varying international requirements. By understanding key differences between patents and copyrights as well as leveraging expert guidance and resources such as WIPO’s PCT system, R&D managers and engineers can better navigate this intricate landscape towards securing robust intellectual property protection for their innovative solutions.
Software patents are complex and require specialized knowledge to navigate the system.
Key Takeaway: Software patents can be difficult to obtain due to their complexity and varying international requirements, but with the help of an experienced patent attorney or agent as well as resources such as WIPO’s PCT system, R&D teams can navigate this tricky landscape and ensure strong IP protection for their inventions.
What Can Be Patented: A Checklist
If you’re an R&D manager, engineer, or scientist working on a new invention, one of the most critical steps in the process is determining whether your idea can be patented. In this article, we’ll provide you with a checklist to help determine what can and cannot be patented.
United States Patent Laws
In the United States, patent laws dictate that patents may only be granted for “any new and useful process, machine, manufacture or composition of matter.” Additionally:
- The invention must not have been previously disclosed publicly (including online).
- The invention must not have been sold or offered for sale more than one year before filing a patent application.
- The invention must not be obvious to someone skilled in the relevant field.

Patentable Subject Matter
To determine if your idea meets these requirements and is eligible for patent protection:
- Determine if it falls under one of the four categories: process (a method), machine (an apparatus), manufacture (an article produced from raw materials), or composition of matter (a chemical compound).
- Evaluate its novelty by conducting a thorough search through existing patents as well as scientific literature databases such as Google Scholar and PubMed. This step will help ensure that your idea has not already been patented by someone else. It’s essential to conduct extensive research because even small differences between inventions could make them ineligible for patent protection.
- Assess its non-obviousness by determining whether the invention is something that someone skilled in the relevant field would have thought of independently. If it’s determined that your idea meets all three criteria, you can then file a patent application with the United States Patent and Trademark Office (USPTO).
Inventions That Cannot Be Patented
While many ideas are eligible for patent protection, there are several categories of inventions that cannot be patented:
- Natural phenomena or laws of nature.
- Abstract ideas or concepts.
- Literary works, music compositions, and other artistic creations (these may be protected under copyright law instead).
- Inventions deemed harmful to public safety or morality such as perpetual motion machines. These types of inventions do not meet the requirements for novelty and usefulness needed to qualify for patent protection.
If you’re unsure if your idea qualifies for a patent, consult with a qualified patent professional who can provide guidance on how best to proceed. Remember – obtaining a patent can take time and money but could ultimately protect your invention from competitors while allowing you to profit from its commercialization.
Conclusion
Now we have answered: what can be patented? One must consider the legal requirements for patentability and associated expenses to decide if their invention is suitable for protection.
Realizing the criteria for patenting and associated expenses is fundamental to deciding if your creation is eligible for legal defense. With careful consideration of all these factors, you’ll have a better understanding of whether or not your invention can be patented and how best to protect it from infringement.
Discover the power of Cypris and unlock the potential to patent your innovations faster with our comprehensive research platform. Leverage data-driven insights to maximize R&D efficiency and accelerate innovation cycles.
Patent Basics for R&D Teams: What Can Be Patented?

What can be patented? In this article, we will discuss the types of inventions that can be patented and delve into the requirements for patentability. We’ll delve into the advantages of safeguarding your invention with a patent and provide an overview of how to obtain one in the US, from initial filing through completion.
Furthermore, understanding what cannot be patented is equally important. We will examine laws and regulations governing patent eligibility while identifying certain types of inventions that do not qualify for patents. This knowledge will help you identify potential alternatives to protect your innovative ideas.
In order to determine if your invention is eligible for a patent or not, our guide offers practical steps such as conducting thorough research on existing patents and the prior art, consulting with experts in your field, analyzing novelty and non-obviousness criteria, along with considering commercial potential. So let’s answer the question: what can be patented?
Table of Contents
- What Can Be Patented?
- Machines Eligible for Patent Protection
- Medicines and Chemical Compositions that are Patentable
- Processes Meeting Patentability Criteria
- Software Patents Challenges
- Software Patents vs Copyrights
- Obtaining International Software Patents
- What Can Be Patented: A Checklist
- United States Patent Laws
- Patentable Subject Matter
- Inventions That Cannot Be Patented
- Conclusion
What Can Be Patented?
The USPTO bestows patents on novel, utilitarian and creative ideas. These can include machines, medicines, computer programs, articles made by machines, compositions of matter such as chemicals or biogenetic materials, processes (an act or series of acts that produce an article), and even some software applications. However, laws of nature cannot be patented nor can any invention be deemed contrary to the public good.
Machines Eligible for Patent Protection
To be eligible for patent protection, a machine must be novel, have utility and not appear obvious to someone knowledgeable in the relevant field. Examples of patented machines range from simple devices like staplers to complex systems like autonomous vehicles.
Medicines and Chemical Compositions that are Patentable
New pharmaceutical drugs with therapeutic effects on humans or animals are eligible for patent protection if they demonstrate novelty and usefulness. Chemical compounds used in various industries such as agriculture or manufacturing may also receive patents if they meet these same requirements.
Vaccines developed using innovative techniques can potentially obtain a patent due to their unique composition of matter.
Processes Meeting Patentability Criteria
A process is defined as an act or series of acts that produce an article; this includes methods utilized within various fields including engineering design processes. This could involve creating new materials through specific treatments applied during production stages leading up to the final product assembly steps.
Processes can be patented if they are novel, useful, and non-obvious to a person skilled in the relevant field. Examples of patentable processes include manufacturing techniques for producing semiconductors or methods for purifying water.
To qualify for a patent, an invention must satisfy certain requirements.
Key Takeaway: What can be patented? The USPTO grants patents for new, useful, and nonobvious inventions such as machines, medicines, and processes. To be eligible for patent protection in the United States Patent system an invention must have novelty, utility and not be obvious to someone skilled in that field.
Software Patents Challenges
What can be patented? Can software be patented?
While software is eligible for both patent and copyright protection, obtaining a software patent can be quite challenging due to its complex nature. The intricate algorithms, data structures, and other technical facets of software inventions may prove difficult for those without specialized knowledge to comprehend. Furthermore, international patents for software can incur substantial costs and require extensive documentation.
Software Patents vs Copyrights
A key distinction between patents and copyrights lies in the type of protection they offer. While patents protect the underlying ideas or concepts behind an invention (such as a novel algorithm), copyrights safeguard the expression of those ideas (e.g., source code). As such, it’s essential for R&D managers, engineers, scientists, and commercialization teams to understand these differences when deciding on their intellectual property strategy.
In general terms:
- Patents: Grant exclusive rights to inventors over their inventions for a limited period (usually 20 years) in exchange for public disclosure of their work.
- Copyrights: Protect original works of authorship fixed in tangible mediums – including computer programs – against unauthorized copying or distribution without permission from copyright holders; typically lasts much longer than patent protection (life plus 70 years).
Obtaining International Software Patents
Filing international patent applications can be particularly daunting given varying requirements across different jurisdictions. For example: if you invent a new method for interchanging data between a smartphone and a thermostat internationally, there may be substantial costs involved in submitting international patent applications.
Additionally, navigating the legal landscape of each country’s patent office can prove to be time-consuming and resource-intensive.
To help overcome these challenges, consider the following steps:
- Consult with a Patent Professional: Engage an experienced patent attorney or agent who specializes in software patents to guide you through the process and ensure that your application meets all necessary requirements.
- Conduct Thorough Prior Art Searches: Before filing your application, perform comprehensive searches for existing patents and publications that could potentially affect your invention’s novelty or non-obviousness criteria – crucial factors when determining patent eligibility.
- Leverage International Filing Systems: Utilize global systems like the World Intellectual Property Organization’s Patent Cooperation Treaty (PCT) system to streamline filing processes across multiple countries. Meanwhile, you can defer national phase entry deadlines up to 30 months from the priority date, allowing more time for strategic decision-making regarding market entry plans.
Obtaining software patents can pose unique challenges due to their inherent complexity and varying international requirements. By understanding key differences between patents and copyrights as well as leveraging expert guidance and resources such as WIPO’s PCT system, R&D managers and engineers can better navigate this intricate landscape towards securing robust intellectual property protection for their innovative solutions.
Software patents are complex and require specialized knowledge to navigate the system.
Key Takeaway: Software patents can be difficult to obtain due to their complexity and varying international requirements, but with the help of an experienced patent attorney or agent as well as resources such as WIPO’s PCT system, R&D teams can navigate this tricky landscape and ensure strong IP protection for their inventions.
What Can Be Patented: A Checklist
If you’re an R&D manager, engineer, or scientist working on a new invention, one of the most critical steps in the process is determining whether your idea can be patented. In this article, we’ll provide you with a checklist to help determine what can and cannot be patented.
United States Patent Laws
In the United States, patent laws dictate that patents may only be granted for “any new and useful process, machine, manufacture or composition of matter.” Additionally:
- The invention must not have been previously disclosed publicly (including online).
- The invention must not have been sold or offered for sale more than one year before filing a patent application.
- The invention must not be obvious to someone skilled in the relevant field.

Patentable Subject Matter
To determine if your idea meets these requirements and is eligible for patent protection:
- Determine if it falls under one of the four categories: process (a method), machine (an apparatus), manufacture (an article produced from raw materials), or composition of matter (a chemical compound).
- Evaluate its novelty by conducting a thorough search through existing patents as well as scientific literature databases such as Google Scholar and PubMed. This step will help ensure that your idea has not already been patented by someone else. It’s essential to conduct extensive research because even small differences between inventions could make them ineligible for patent protection.
- Assess its non-obviousness by determining whether the invention is something that someone skilled in the relevant field would have thought of independently. If it’s determined that your idea meets all three criteria, you can then file a patent application with the United States Patent and Trademark Office (USPTO).
Inventions That Cannot Be Patented
While many ideas are eligible for patent protection, there are several categories of inventions that cannot be patented:
- Natural phenomena or laws of nature.
- Abstract ideas or concepts.
- Literary works, music compositions, and other artistic creations (these may be protected under copyright law instead).
- Inventions deemed harmful to public safety or morality such as perpetual motion machines. These types of inventions do not meet the requirements for novelty and usefulness needed to qualify for patent protection.
If you’re unsure if your idea qualifies for a patent, consult with a qualified patent professional who can provide guidance on how best to proceed. Remember – obtaining a patent can take time and money but could ultimately protect your invention from competitors while allowing you to profit from its commercialization.
Conclusion
Now we have answered: what can be patented? One must consider the legal requirements for patentability and associated expenses to decide if their invention is suitable for protection.
Realizing the criteria for patenting and associated expenses is fundamental to deciding if your creation is eligible for legal defense. With careful consideration of all these factors, you’ll have a better understanding of whether or not your invention can be patented and how best to protect it from infringement.
Discover the power of Cypris and unlock the potential to patent your innovations faster with our comprehensive research platform. Leverage data-driven insights to maximize R&D efficiency and accelerate innovation cycles.
Keep Reading

A prompt is a single instruction issued to a language model, executed once, by one person, in a context nobody else can see. An agent is an encoded workflow with a defined scope, a defined corpus, defined evidence standards, and defined output structure, executed the same way every time regardless of who runs it. The difference between them is not sophistication. It is control.
This distinction matters more in R&D than in almost any other enterprise function, because R&D decisions carry long horizons and large capital commitments, and because the analysis behind those decisions has to survive scrutiny from stage-gate committees, IP counsel, regulators, and partners. An analysis that cannot be reproduced cannot be defended. Most AI-assisted R&D work today is prompt-based, which means most of it cannot be reproduced.
The industry conversation has spent three years on prompt engineering as the path to better AI output. For exploratory work, that framing holds. For the recurring, decision-bearing analyses that R&D organizations actually run, it is the wrong problem entirely. The question is not how to write a better prompt. It is how to stop treating a repeated organizational process as an improvised individual act.
What a Prompt Actually Is
Strip away the tooling and a prompt is a one-time instruction with no persistence, no version, no scope definition, and no record of what informed it.
Consider what happens when a research scientist asks a general-purpose AI tool to summarize the competitive position in a technology domain. The model receives the question, retrieves or recalls whatever material it has access to, applies whatever reasoning the phrasing invites, and returns a fluent answer. The scientist reads it, adjusts the phrasing, asks again, gets a different answer, and keeps the one that seems best.
Four things about that process are worth naming precisely.
The instruction was never written down in a form anyone else can reuse. It exists in a chat window that will be closed. The next person who needs the same analysis will write their own instruction, differently.
The scope was never defined. The model decided what counted as in-scope based on inference from the question, and that inference is invisible. Two colleagues asking what they believe is the same question will get answers drawn from materially different material.
The evidence standard was never set. Nothing specified whether a claim required a citation, whether the citation had to resolve to a real document, or what counted as sufficient support for a conclusion. The output looks equally authoritative whether it is grounded or invented.
And the selection was unrecorded. The scientist ran the query several times and kept the version they preferred. That is a legitimate exploratory behavior and a serious problem if the retained answer becomes an input to a funding decision, because the discarded answers were part of the process and no longer exist.
None of this is a criticism of the scientist. It is a description of what a prompt is. A prompt has no mechanism for carrying any of that structure, which is why the same person asking the same question on two different days can get two different answers and have no way to explain the divergence.
What an Agent Actually Is
An agent is not a better prompt. It is a different category of artifact, and the clearest way to understand the difference is that an agent is written once and executed many times, whereas a prompt is written every time it is executed.
A properly constructed agent for R&D work encodes five things.
It encodes the scope, meaning the explicit boundaries of what the analysis covers, including the technology domain, geography, time range, adjacent areas treated as in-scope, and areas explicitly excluded. This is written down and is the same for every execution.
It encodes the corpus, meaning which datasets the analysis runs against and which it does not. Not an undifferentiated index that the model searches at its discretion, but a defined document set with stated inclusion criteria.
It encodes the method, meaning the sequence of analytical passes the agent performs and the order it performs them in. A landscape agent runs an activity pass, an actor pass, a structural pass, a temporal pass, and a gap pass because that sequence is written into the workflow, not because a given prompt happened to invite it.
It encodes the evidence standard, meaning what constitutes adequate support for a claim, whether citations are mandatory, and what the agent does when it cannot substantiate a finding.
And it encodes the output structure, meaning the shape of the deliverable, so that two analyses of two different technology domains produce comparable documents that can be evaluated side by side.
The consequence is that an agent produces the same analysis regardless of who invokes it. A junior researcher and a twenty-year veteran running the same agent on the same question get the same methodology applied. The veteran will interpret the output better, which is where their expertise should be spent. But the analysis itself is no longer a function of who happened to run it.
The Four Failures of Prompt-Based R&D Work
The practical costs of prompt-based analysis show up in four ways, and they compound.
The first is irreproducibility. If a program was killed eight months ago based on an AI-assisted landscape analysis, and someone now asks why, the honest answer under a prompt-based process is that nobody can reconstruct it. The chat is gone, the phrasing is unrecorded, and rerunning a similar query today produces a different answer against a corpus that has since changed. For organizations in regulated industries, and for any organization where R&D decisions are subject to internal audit, this is not a minor inconvenience.
The second is invisible variance. When five people on a team each prompt their way to an answer, the organization has five methodologies it cannot see. The outputs will look similar because they share a format and a tone. The analytical rigor behind them will vary enormously, and there is no way to tell which is which by reading them. Fluency conceals variance in a way that a spreadsheet never did.
The third is the absence of an audit trail. Enterprise agent architectures now treat full audit logging as a baseline requirement, capturing each instruction, intermediate reasoning step, model output, and tool call [1]. Prompt-based work has none of this by construction. When a finding turns out to be wrong, there is no way to determine whether the error came from the corpus, the framing, the model, or the interpretation, which means the error cannot be prevented from recurring.
The fourth, and the most consequential over time, is that knowledge stays with individuals. When someone becomes genuinely good at getting useful output from AI tools for patent landscape work, that skill lives in their head. It leaves when they leave. It does not transfer to their replacement, it does not raise the floor for the rest of the team, and the organization pays to develop it again. Prompt skill is a personal capability. Agent configuration is an institutional asset.
Standardization Is the Actual Product
The value proposition of agents in R&D is usually pitched as autonomy, meaning the agent works while you sleep. That is real but secondary. The primary value is standardization, and it produces four things that prompt-based work structurally cannot.
It produces comparability. When every technology domain in a portfolio is assessed through the same agent, the resulting analyses can be placed side by side and ranked. Under prompt-based work, differences between two analyses reflect differences in who ran them as much as differences in the underlying domains, which makes portfolio-level comparison unreliable.
It produces defensibility. A stage-gate committee asking how a conclusion was reached can be shown the agent configuration, the corpus definition, the analytical sequence, and the source documents behind each claim. This is the difference between an analysis and an opinion with citations.
It produces improvability. A methodology that is written down can be reviewed, criticized, and revised. When a landscape analysis misses a competitor because the corpus excluded a jurisdiction, that is a fixable configuration error, and the fix applies to every future execution. When the same thing happens under prompt-based work, it is an anecdote.
And it produces institutional memory. An agent library is an encoded record of how an organization does its analytical work. It is the R&D equivalent of a standard operating procedure, and it accrues value in the same way, by capturing what the organization has learned about how to do the work well.
Where Prompts Still Belong
The argument is not that prompting is obsolete. It is that prompting and agents solve different problems, and most organizations are using one for both.
Prompts are the right tool for exploration, where the question itself is still forming and the value comes from fast iteration. A researcher trying to understand an unfamiliar technical area, testing whether a hypothesis is worth pursuing, or working out how to frame a problem is doing work that would be slowed down, not improved, by a standardized workflow. Exploratory work is supposed to be idiosyncratic.
Agents are the right tool for any analysis that is recurring, decision-bearing, or subject to review. Landscape analysis, freedom-to-operate assessment, prior art review, technology scouting, competitive monitoring, and portfolio evaluation all meet at least two of those three criteria, and most meet all three.
The practical test is a question: if two people on this team performed this analysis independently, would we expect the same answer, and would it matter if we did not get it? When the answer to the second part is yes, the work belongs in an agent.
The R&D Organization of the Next Five Years
Agents change what R&D teams look like, and the changes are more structural than the current productivity framing suggests. Five shifts are already visible.
The analyst role moves up a level. The work of performing analysis moves into agents. The work of designing analysis, auditing it, and interpreting it stays with people and becomes more valuable. This is not a headcount story in either direction. It is a change in what R&D analysts are for. The skill that appreciates is knowing what question to ask, what evidence would answer it, and what the output is not telling you. The skill that depreciates is executing search syntax and building charts.
Intelligence becomes ambient rather than requested. The current model is that someone asks for a landscape analysis, waits several weeks, and receives a document that begins aging on delivery. The agent model is that the analysis runs continuously and surfaces findings when they meet a defined threshold. The organizational consequence is significant: R&D teams stop making decisions against a stale snapshot and start operating with a maintained view. It also removes the request-and-wait friction that currently causes teams to skip the analysis entirely on smaller decisions.
Methodology becomes a company asset. Organizations will maintain agent libraries the way they maintain SOPs, with versioning, ownership, and review cycles. How your company runs a freedom-to-operate assessment will become a documented, improvable thing rather than a set of habits distributed across a few experienced people. This is the shift with the longest-term competitive effect, because it means analytical quality compounds within the organization instead of walking out the door periodically.
Evidence standards at stage-gate rise. When it becomes cheap to produce a rigorous, cited, reproducible analysis, the bar for what counts as adequate diligence moves. Committees will start asking which agent produced a finding, what corpus it ran against, and when it last executed. Programs supported by an unverifiable summary will face harder questions than they do today. This is a good outcome, and it will be uncomfortable for a while.
Governance becomes the binding constraint. This is the shift most organizations are underestimating. IBM's 2026 study found 94% of enterprises report that AI sprawl is raising security risk and operational complexity, with agents proliferating across teams and frameworks in ways that produce fragmentation rather than capability [2]. Deloitte's 2026 research found that only 21% of surveyed organizations have a mature AI-agent governance model while roughly 75% intend to deploy agentic AI within two years [3]. KPMG tracked enterprise agent deployment rising from 11% to 42% over 2025 before falling back to 26% in the fourth quarter, a pullback attributed to leaders shifting from pilots toward professionalizing and scaling their agent systems [3].
That pullback is the most instructive data point in the set. It is not evidence that agents failed. It is evidence that organizations discovered the hard part is not building an agent, it is running a governed portfolio of them. R&D organizations that treat agent standardization as an operating discipline rather than a tool purchase will be the ones that get through that transition without accumulating the sprawl everyone else is now trying to consolidate.
What to Do Now
The first step is an inventory, not a purchase. Identify the analyses your R&D organization performs repeatedly and that inform resource commitments. For most enterprise teams that list includes landscape analysis, freedom-to-operate, prior art review, technology scouting, competitor monitoring, and partner or acquisition screening.
The second step is to write down how one of them is actually performed today. Not how the process document says it is performed, but what the person who does it actually does. This is usually uncomfortable, because the honest version reveals how much of the method exists only in one person's judgment.
The third step is to encode that method as an agent configuration with explicit scope, corpus, analytical sequence, evidence standard, and output structure, and to treat that configuration as a versioned artifact with an owner.
The fourth step is to run it in parallel with the existing process for a cycle and compare. The point is not to prove the agent is faster. It is to find where the encoded method and the human method diverge, because those divergences are where the undocumented expertise lives, and capturing them is the actual work.
How Cypris Approaches This
Cypris is an AI-native R&D intelligence platform built around the premise that the recurring analyses R&D and IP teams depend on should be standardized workflows rather than improvised queries.
Cypris Q, the platform's agentic layer, runs patent landscape analysis, white space mapping, freedom-to-operate, technology scouting, and competitive intelligence as domain workflows rather than as raw prompts. The distinction is the one this article describes. The agent already carries the structure of the analysis, meaning it knows how to frame the question, which analytical passes to run, what constitutes a finding, and how to shape the output. A user is not responsible for reconstructing the methodology in a prompt each time, which is what makes output consistent across people and across executions.
The workflows run against a corpus of more than 500 million patents and scientific papers organized through a proprietary R&D ontology. The ontology matters for standardization specifically, because it means the agent resolves terminology variation across jurisdictions and research traditions the same way every time, rather than depending on whether a given user happened to include the right synonyms in their query. Teams can also configure custom corpora of patent and non-patent literature scoped to a particular domain, which makes the corpus definition an explicit, reviewable part of the workflow rather than an invisible model decision.
Output is generated with citations anchored to verifiable source records. This is the evidence standard component, and it is what allows an analysis to be checked rather than trusted.
Agentic Monitoring, launched in June 2026, is the persistence layer. It runs continuously across patent offices, scientific literature, chemical compound databases, regulatory bodies, M&A activity, product launches, grant awards, and corporate news [4]. Teams define their monitoring domains once and receive filtered, contextualized intelligence on a defined cadence. This is the operational form of the ambient intelligence shift described above, converting periodic manual rebuilds into a maintained baseline with exception reporting.
For organizations standardizing on general-purpose AI platforms, Cypris exposes the same layer through an MCP server and through enterprise API partnerships with OpenAI, Anthropic, and Google. In August 2026 the company launched Cypris Q for Microsoft Copilot, allowing teams to call Cypris agents for landscape analysis, prior art research, technology scouting, and competitive intelligence from within their existing Microsoft environment [5]. The design principle is consistent with the argument here: the general-purpose model supplies reasoning and interface, while the domain layer supplies the standardized method and the grounded corpus.
Cypris serves hundreds of enterprise customers and thousands of researchers across pharmaceuticals, chemicals, advanced materials, and electronics, with enterprise-grade security meeting Fortune 500 requirements.
The Underlying Point
Every organization that has industrialized a knowledge process went through the same transition, from skilled individuals doing the work their own way to a documented method executed consistently. Manufacturing did it. Clinical research did it. Software engineering did it. R&D intelligence is going through it now, and the transition is being obscured by a conversation about prompting that frames an organizational problem as a personal skill.
The teams that will be ahead in three years are not the ones with the best prompt engineers. They are the ones that stopped needing them.
Frequently Asked Questions
What is the difference between a prompt and an AI agent?
A prompt is a single instruction issued to a language model, executed once, with no persistent record of its scope, corpus, or evidence standard. An AI agent is an encoded workflow that defines scope, corpus, analytical method, evidence standards, and output structure in advance, and executes the same way every time regardless of who invokes it. The difference is standardization and reproducibility rather than sophistication.
Why are prompts a problem for R&D analysis specifically?
R&D decisions carry long horizons and large capital commitments, and the analyses supporting them are reviewed by stage-gate committees, IP counsel, and sometimes regulators. Prompt-based analysis cannot be reproduced, contains invisible variation between users, and generates no audit trail, which means a conclusion cannot be reconstructed or defended after the fact.
Is prompt engineering still useful?
Yes, for exploratory work where the question is still forming and rapid iteration is the point. Prompting is the wrong approach for analyses that recur, that inform resource commitments, or that are subject to review, because those require consistency across people and executions that a prompt cannot provide.
What makes an AI agent standardized?
A standardized agent encodes five components in advance: the scope of the analysis including explicit inclusions and exclusions, the corpus it runs against, the sequence of analytical passes it performs, the evidence standard governing what constitutes a supported claim, and the structure of the output. Because these are written once and executed many times, two different people running the agent receive the same methodology.
Can an AI agent replace R&D analysts?
No. Agents absorb the execution of analysis, while designing the analysis, auditing its output, and interpreting findings remain human work and become more valuable. The skill that appreciates is knowing what question to ask and what the output is not showing. The skill that depreciates is executing search syntax and producing charts.
How will AI agents change R&D teams?
Five shifts are underway: analyst work moves from performing analysis to designing and auditing it; intelligence becomes continuous rather than requested on demand; analytical methodology becomes a documented company asset rather than individual expertise; evidence standards at stage-gate reviews rise as rigorous analysis becomes cheaper to produce; and agent governance becomes the primary organizational constraint on scaling.
What is agent sprawl and why does it matter for R&D?
Agent sprawl is the proliferation of AI agents built independently across teams, functions, and frameworks without shared governance. IBM's 2026 Institute for Business Value study found 94% of enterprises report AI sprawl is raising security risk and operational complexity. For R&D organizations, sprawl reintroduces the variance problem that agents were meant to solve, because ten ungoverned agents produce the same inconsistency as ten people prompting.
How mature is enterprise agent governance?
Low relative to deployment intent. Deloitte's 2026 research across more than 3,200 director-level and C-suite respondents found only 21% of organizations have a mature AI-agent governance model while approximately 75% plan to deploy agentic AI within two years. KPMG tracked deployment rising from 11% to 42% across 2025 before pulling back to 26% in the fourth quarter, attributed to leaders moving from pilots to professionalizing agent systems.
How do you turn an existing R&D analysis into an agent?
Start by documenting how the analysis is actually performed today rather than how the process document describes it. Then encode that method as a configuration with explicit scope, corpus, analytical sequence, evidence standard, and output structure, treated as a versioned artifact with a named owner. Run it in parallel with the existing process for one cycle and examine where the encoded and human methods diverge, since those divergences identify the undocumented expertise that needs capturing.
What tools run standardized R&D agent workflows?
Enterprise R&D intelligence platforms are the category built for this. Cypris runs patent landscape analysis, white space mapping, freedom-to-operate, and technology scouting as domain workflows through Cypris Q, its agentic layer, against a corpus of more than 500 million patents and scientific papers organized through a proprietary R&D ontology, with continuous execution through Agentic Monitoring and access through an MCP server, enterprise API partnerships with OpenAI, Anthropic, and Google, and Cypris Q for Microsoft Copilot.

A patent landscape analysis is a structured assessment of the intellectual property and technical activity in a defined technology domain, conducted to answer a specific strategic question about where innovation is concentrated, who is driving it, and where the remaining opportunity sits. For corporate R&D teams, it is the analysis that determines which research programs get funded, which partnerships get pursued, and which technology bets get abandoned before resources are committed.
The methodology most teams still follow was designed for a different era of data volume and a different kind of tooling. It assumes a human analyst constructing Boolean queries against a patent database, exporting results to a spreadsheet, manually classifying records into technology buckets, and building charts that summarize assignee counts and filing trends over time. That process produces a deliverable, but it takes weeks, it degrades the moment new filings publish, and it answers a narrower question than the one leadership actually asked.
This guide covers the modern methodology. The two changes that matter most are that the analytical work is now performed by a curated AI agent rather than by manual query construction, and that the corpus the analysis runs against must extend well beyond patents to be strategically useful. Everything else in the process follows from those two shifts.
What a Patent Landscape Analysis Is and What It Is Not
A patent landscape analysis maps the competitive and technical structure of a technology domain using the documented innovation record. It identifies who is active, what they are working on, how their activity has changed over time, where activity clusters, and where it thins out.
It is distinct from three adjacent workflows that teams often conflate with it. A prior art search establishes whether a specific invention is novel. A freedom-to-operate analysis assesses whether commercializing a specific product would infringe active claims in target markets. A technology scouting exercise looks forward to identify emerging capabilities and potential partners. A landscape analysis is broader than the first two and more structured than the third. It produces the map that the other three operate on.
The strategic value of a landscape analysis comes from what it enables downstream. It informs portfolio strategy by showing where a company's own filings sit relative to competitors. It informs research prioritization by revealing which technical approaches are crowded and which are underexplored. It informs partnership and acquisition strategy by surfacing which organizations hold positions a company lacks. And it informs risk assessment by identifying the density of third-party claims a program will eventually have to navigate.
Why the Traditional Methodology Now Fails
Three structural problems have made manual landscape analysis unreliable for enterprise decision-making.
The first is volume. Global patent filings reached 3.7 million in 2025, the fastest annual growth since 2018, and scientific publications passed 2 million articles in the same year [1]. A technology domain that produced a manageable result set five years ago now returns volumes that exceed what a human analyst can read, let alone classify with consistency. Teams respond by narrowing the query until the result set is manageable, which reintroduces the sampling error the analysis was supposed to eliminate.
The second is vocabulary. Technical language varies across jurisdictions, research traditions, corporate filing practices, and time periods. Patent attorneys draft claims to broaden coverage, which frequently means describing a well-known technique in unfamiliar terms. A keyword-driven query finds documents that use the analyst's vocabulary and misses documents that use anyone else's. Classification codes help but were not designed to track technologies that cross established categories, which describes most of the technologies enterprises care about.
The third is latency. Patents publish eighteen months after their priority date in most jurisdictions. A landscape built exclusively on the patent record is therefore a picture of competitive positioning as it existed a year and a half ago, presented as though it describes the present. For slow-moving domains this matters less. For domains where the competitive position can shift within a single funding cycle, it produces confident conclusions about a world that no longer exists.
None of these problems are solved by running the same manual process faster. They are solved by changing what the analysis runs against and what performs the analysis.
The Case for a Multi-Dataset Corpus
The single most consequential decision in a modern landscape analysis is what goes into the corpus. Most teams treat this as settled, because the workflow is called patent landscape analysis and the obvious input is patents. That assumption is where the majority of landscape analyses go wrong.
Patent data is a record of what organizations chose to protect, filed through a legal process, published on a statutory delay. It is a high-quality signal about competitive intent, and it is incomplete in specific and predictable ways. Research published in the patentometrics literature makes the limitation explicit, noting that a comprehensive technical assessment would ideally integrate patent records with experimental, clinical, and industrial data, and that patent-only analysis is intentionally scoped to innovation trends and knowledge flows rather than to the full technical picture [2].
Consider what patent-only analysis structurally cannot see. It cannot see work that organizations deliberately keep as trade secrets, which is common in process chemistry, manufacturing methods, and formulation. It cannot see defensive publications filed specifically to block others without seeking protection. It cannot see academic and national-lab research that will become commercially relevant but has not yet been commercialized by anyone. It cannot see regulatory filings that reveal which compounds and devices are actually moving toward market. It cannot see funding activity, which is often the earliest reliable indicator that a technical approach has attracted serious capital. And it cannot see hiring, acquisition, and facility investment, which indicate where organizations are building capability ahead of any filing.
The practical consequence is that a patent-only landscape systematically overstates the position of organizations with aggressive filing strategies and understates the position of organizations that protect through secrecy or that are still upstream of commercialization. A landscape of a chemical process domain built only on patents will typically miss the most sophisticated competitors entirely, because the leading process improvements are held as trade secrets.
Scientific literature deserves particular emphasis because of the timing advantage it provides. Publications frequently surface technical developments six to eighteen months before associated patents publish, and often earlier, because academic and corporate research groups publish results well ahead of the point at which a commercial application becomes patentable. Adding literature to the corpus moves the early-warning signal forward by roughly the length of the patent publication delay, which is to say it substantially eliminates the latency problem described above.
A properly constructed corpus for enterprise landscape work therefore includes global patent records, peer-reviewed and preprint scientific literature, regulatory filings and approvals in relevant jurisdictions, grant and public funding awards, clinical or field trial registries where applicable, corporate disclosures including M&A and product launches, and where relevant, chemical structure and reaction data. The point is not to maximize volume. The point is that each dataset covers a blind spot in the others, and the strategic question the analysis is meant to answer almost always spans more than one of them.
Step One: Define the Strategic Question, Not the Technology Field
The traditional first step is scope definition: name the technology domain, set the geography, set the date range, list the competitors. That step is still necessary, but it is not the first step, and treating it as the first step is why so many landscape analyses produce a competent map that answers nothing.
Start instead with the decision the analysis exists to support. "Should we build internal capability in solid-state electrolytes or license it" is a different question from "which organizations lead in solid-state electrolytes," and the two require different corpora, different classification schemes, and different outputs. A licensing question requires depth on assignee portfolios, claim scope, and expiry timelines. A build-versus-buy question requires depth on capability signals, hiring, funding, and academic pipelines.
Write the question down before defining anything else. Then derive the technology scope, geography, time range, and competitor set from the question rather than from the technology label. Geography should be set by where commercialization will occur and where competitors manufacture, not by convenience. Time range should extend back far enough to capture the technical lineage of the approach, which for most technologies means longer than the five years teams typically default to.
Step Two: Curate the Corpus Before Curating the Agent
Once the question is defined, assemble the datasets that can answer it. This is the step that has no equivalent in the traditional methodology, and it is where most of the analytical quality is determined.
Corpus curation means deliberately selecting and scoping the document set the analysis will reason over, rather than pointing a query at an undifferentiated index. The distinction matters enormously when an AI system is doing the analysis. An agent given the entire global patent record and asked about solid-state electrolytes will retrieve a large volume of loosely related material and reason over a diluted context. An agent given a curated corpus of solid-state electrolyte patents, the relevant electrochemistry literature, the associated grant awards, and the regulatory and safety record will reason over a dense, high-signal context and produce materially better output.
This is the practical answer to the failure mode most teams experience when they try to run landscape analysis through a general-purpose AI tool. The disappointing results are usually not a reasoning failure. They are a retrieval failure. The model was never given the right material, and no amount of prompt refinement compensates for a corpus that does not contain the answer.
Curate deliberately. Include the datasets that cover your question's blind spots. Set inclusion criteria explicitly, including which jurisdictions, which document types, which date boundaries, and which classification codes or subject areas. Document what you excluded and why, because that record is what makes the analysis defensible when someone challenges a conclusion.
Step Three: Configure the Agent's Scope and Reasoning Boundaries
With the corpus set, the next step is configuring the agent that will run the analysis. This is a design exercise, not a prompting exercise, and it has four components.
The first is the strategic envelope, which is the agent's statement of what the analysis is for. This is the strategic question from step one, expressed in enough detail that the agent can distinguish a relevant finding from an interesting one. Without it, the agent optimizes for comprehensiveness and returns everything.
The second is technical and market scope, which defines the boundaries of the domain in the agent's own working vocabulary. This should include the alternative terminology, adjacent technical approaches that should be treated as in-scope, and the approaches that should be treated as out-of-scope even though they will surface. Specifying exclusions is at least as valuable as specifying inclusions.
The third is evidence priorities, which tells the agent what kinds of evidence carry weight for this particular question. A landscape supporting an acquisition decision should weight assignee-level portfolio structure and claim breadth heavily. A landscape supporting a research prioritization decision should weight publication velocity, grant activity, and technical novelty more heavily than filing counts.
The fourth is escalation criteria, which defines what constitutes a finding significant enough to surface prominently rather than list. Without escalation criteria, the agent produces a flat inventory and the human analyst has to do the prioritization work manually, which is most of the work.
A well-configured agent is one where a knowledgeable colleague could read the configuration and correctly predict what the agent would flag and what it would ignore. If the configuration does not support that prediction, it is underspecified.
Step Four: Classify Through an Ontology Rather Than a Flat Taxonomy
The classification step determines what the landscape actually shows. Traditional methodology uses either patent classification codes or a flat taxonomy the analyst constructs by hand, and both approaches struggle with the same problem: technologies that span categories get assigned to one bucket and disappear from the others.
An ontology-based approach handles this differently. Rather than assigning each document to a single category, an ontology represents the relationships between technical concepts, so a document about a solid-state electrolyte using a sulfide chemistry for an automotive application is represented as sitting at the intersection of all three, and appears correctly in any analysis touching any of them. It also resolves the vocabulary problem, because an ontology encodes that different terms across jurisdictions and research traditions refer to the same underlying concept.
This is the difference between a landscape that shows filing counts by assignee and a landscape that shows which technical approaches are converging, which is where most of the strategic value sits. Convergence is invisible in a flat taxonomy because it is a relationship rather than a category.
Step Five: Run the Analytical Passes
With corpus, configuration, and classification in place, the analysis itself runs as a series of passes over the same material, each answering a different part of the strategic question.
The activity pass establishes volume and velocity: how much work is happening in each part of the domain, and whether it is accelerating or slowing. Velocity matters more than volume, because a small but rapidly accelerating cluster is usually a stronger signal than a large stable one.
The actor pass establishes who is active and in what capacity. This should distinguish between organizations filing heavily, organizations publishing heavily, organizations receiving funding, and organizations acquiring capability, because those are four different competitive postures and a patent-only analysis collapses them into one.
The structural pass establishes how the domain is organized: which technical approaches exist, how they relate, where citation and collaboration networks concentrate, and where the boundaries between approaches are dissolving.
The temporal pass establishes how the domain has changed, which requires the analysis to distinguish between genuine shifts in research direction and artifacts of publication delay or filing strategy changes.
The gap pass identifies where activity is sparse. This is the pass that requires the most caution, and the reason is worth stating plainly. An area of the map with few patents is not automatically an opportunity. It may be sparse because the approach was tried and failed, because it is covered by trade secrets, because it is not commercially viable, or because the regulatory pathway is closed. Patent white space and commercial opportunity space are distinct concepts, and treating an empty region of the patent map as an open market is one of the most expensive errors in R&D strategy. A multi-dataset corpus is what allows the gap pass to distinguish between the two, because the literature, regulatory, and funding records will show whether anyone has tried.
Step Six: Validate Before You Synthesize
AI-generated landscape analysis is only usable if every material claim traces to a verifiable source document. This is not a theoretical concern. General-purpose language models asked patent questions will produce plausible patent numbers that do not exist, misstate priority and publication dates, and attribute filings to the wrong assignee, because they are generating from training data rather than retrieving from a live record.
Build validation into the process rather than treating it as a review step. Require that every finding carries a citation to a specific document. Spot-check a sample of citations against the source record, weighted toward the findings that will drive the decision. Verify assignee names against corporate structure, because subsidiaries, joint ventures, and post-acquisition transfers routinely fragment a single competitor's portfolio across several names and make a strong position look weak. Check the date boundaries on any trend claim, because apparent declines in recent filing activity are usually the publication delay rather than a real slowdown.
Step Seven: Synthesize Into a Decision Artifact
The output of a landscape analysis is not the map. It is the answer to the strategic question from step one, supported by the map.
The deliverable should lead with the answer and the confidence level attached to it, followed by the specific evidence that supports it, followed by what the analysis could not determine and why. That last section is what separates a credible analysis from a persuasive one. Every landscape has blind spots, and naming them is what allows the decision-maker to weight the conclusion appropriately.
Visual outputs still matter, but they should be selected to support the argument rather than produced as a standard set. A landscape supporting a build-versus-buy decision needs a capability map by organization. A landscape supporting research prioritization needs a convergence view. Producing all of them regardless of question is a habit from the era when the charts were the deliverable.
Step Eight: Convert the Analysis From an Event to a Process
A landscape analysis begins degrading the day it is delivered. New filings publish, new papers appear, competitors announce, regulators act. The traditional response is to rebuild the analysis quarterly or annually, which means the organization operates on a picture that is between one and twelve months stale, and the rebuild consumes the same effort every cycle.
The alternative is to treat the configured agent as a persistent asset. Once the corpus is curated and the agent is configured, the same configuration can run continuously, evaluating new material against the strategic question as it appears and surfacing only what meets the escalation criteria defined in step three. The initial landscape becomes the baseline, and the ongoing work becomes exception handling rather than reconstruction.
This is the largest practical return on the agent-curation approach. The configuration work in steps two and three is front-loaded and non-trivial. It pays back over every subsequent cycle, because the expensive part of the traditional process was never the searching. It was the rebuilding.
Common Failure Modes
The most common failure is scoping to the technology instead of to the decision, which produces a comprehensive map that supports no particular conclusion.
The second is corpus poverty, where the analysis runs against patents alone and reaches confident conclusions about domains where the most important activity is not patented.
The third is treating white space as opportunity, addressed above, which is the failure with the highest cost attached to it.
The fourth is unvalidated AI output, where the analysis is fluent, well-organized, and contains fabricated citations that nobody checked because the document read as authoritative.
The fifth is the assignee fragmentation error, where a competitor's position is understated because their portfolio is distributed across subsidiaries and acquisition vehicles that were never consolidated.
The sixth is treating the analysis as a deliverable rather than a capability, which guarantees the organization pays the full cost again next cycle.
Tooling for Landscape Analysis
The tools available for this work fall into three categories, and the distinction matters because they were built for different users.
Free and open resources including Google Patents, The Lens, and PQAI provide access to patent records and, in some cases, linked scholarly data. They are appropriate for verification, spot-checking, and early scoping. They do not provide the corpus curation, agent configuration, or continuous execution that enterprise landscape work requires.
Legacy professional platforms including Derwent Innovation and Orbit Intelligence from Questel provide curated patent data, sophisticated search syntax, and analytical tooling built over decades. They were designed for IP professionals conducting prosecution and litigation support work, and their strengths reflect that: claim-level precision, family management, and legal status tracking. Their limitation for landscape work is that they are patent-centric by design, and the search-and-export workflow assumes a human analyst performing the reasoning.
Enterprise R&D intelligence platforms are the category built for the methodology described in this guide, combining multi-dataset corpora with agentic execution and continuous operation.
How Cypris Supports Patent Landscape Analysis
Cypris is an AI-native R&D intelligence platform built for corporate R&D teams, IP managers, and innovation strategists conducting landscape, white space, freedom-to-operate, and technology scouting work. It is designed around the two shifts this guide describes: a corpus that extends beyond patents, and analysis performed by domain-configured agents rather than manual query construction.
The platform runs on a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology is the component that addresses the classification problem described in step four. Rather than assigning documents to flat categories, it represents relationships between technical concepts, so cross-category technologies appear correctly wherever they are relevant and terminology variation across jurisdictions and research traditions resolves to the same underlying concept. This is what allows convergence analysis, which is invisible to classification-code approaches.
Corpus curation is directly supported. Teams can configure custom corpora of patent and non-patent literature scoped to a specific technology domain and strategic question, which is the step-two work described above. Scoping retrieval before it reaches the model is the practical answer to the context degradation problem that causes general-purpose AI tools to produce diluted output on technical questions.
Cypris Q, the platform's agentic layer, runs patent landscape analysis, white space mapping, freedom-to-operate, and technology scouting as domain workflows rather than as raw queries. The distinction is that the agent already carries the structure of the analysis, so it knows how to frame a landscape question, which passes to run, and what constitutes a finding, rather than requiring the user to specify the methodology in a prompt. Output is generated with citations anchored to verifiable source records, which supports the validation requirements in step six.
Agentic Monitoring, launched in June 2026, addresses step eight. It runs continuously across patent offices, scientific literature, chemical compound databases, regulatory bodies, M&A activity, product launches, grant awards, and corporate news [3]. Teams define their monitoring domains once, and the agents deliver filtered, contextualized intelligence on a cadence that fits the workflow. In landscape terms, this converts the quarterly manual rebuild into a maintained baseline with exception reporting, and it is the mechanism by which the multi-dataset argument becomes operational rather than aspirational.
For teams that have standardized on general-purpose AI platforms, Cypris exposes the same intelligence layer through an MCP server and through enterprise API partnerships with OpenAI, Anthropic, and Google. In August 2026 the company launched Cypris Q for Microsoft Copilot, which allows enterprise teams to call Cypris agents for landscape analysis, prior art research, technology scouting, and competitive intelligence from within their existing Microsoft environment [4]. The design principle is that the base model provides the reasoning and conversational interface while the domain layer scopes retrieval and supplies the structure, which is the pattern that produces reliable output on technical questions.
Cypris serves hundreds of enterprise customers and thousands of researchers across pharmaceuticals, chemicals, advanced materials, electronics, and other technical industries, with enterprise-grade security meeting Fortune 500 requirements.
Getting Started
If your team currently rebuilds landscape analyses manually each quarter, the highest-return change is not adopting an AI tool. It is writing down the strategic question the analysis exists to answer, auditing which datasets can actually answer it, and noticing how many of them are missing from your current corpus. The agent configuration follows from that, and the continuous operation follows from the configuration.
Frequently Asked Questions
What is a patent landscape analysis?
A patent landscape analysis is a structured assessment of the intellectual property and technical activity within a defined technology domain, conducted to determine where innovation is concentrated, which organizations are driving it, how the domain has evolved, and where opportunity remains. It informs portfolio strategy, research prioritization, partnership decisions, and risk assessment for corporate R&D and IP teams.
How is a patent landscape analysis different from a freedom-to-operate analysis?
A patent landscape analysis maps the competitive and technical structure of an entire technology domain to support strategic decisions. A freedom-to-operate analysis assesses whether a specific product or process would infringe active patent claims in target markets. Landscape analysis is broad and strategic; freedom-to-operate is narrow and legal. Landscape analysis typically precedes freedom-to-operate in the R&D workflow.
What are the steps in a patent landscape analysis?
The modern methodology has eight steps: define the strategic question the analysis must answer, curate a multi-dataset corpus scoped to that question, configure the analytical agent's scope and reasoning boundaries, classify the corpus through an ontology rather than a flat taxonomy, run analytical passes covering activity, actors, structure, temporal change, and gaps, validate all findings against source documents, synthesize a decision artifact that leads with the answer, and convert the configured analysis into continuous monitoring.
Should a patent landscape analysis include non-patent data?
Yes. Patent data records what organizations chose to legally protect and publishes on a statutory delay of roughly eighteen months. It cannot capture trade secrets, defensive publications, pre-commercial academic research, regulatory activity, or funding signals. Scientific literature typically surfaces technical developments six to eighteen months before associated patents publish. A corpus including patents, scientific literature, regulatory filings, grant awards, corporate disclosures, and where relevant chemical structure data produces a materially more accurate landscape than patents alone.
Can AI conduct a patent landscape analysis?
AI can perform the analytical work in a patent landscape analysis when it is given a curated corpus and configured for the specific strategic question. Output quality depends primarily on corpus construction and agent configuration rather than on prompting. General-purpose language models querying from training data rather than retrieving from a live record will produce fabricated patent numbers, incorrect dates, and misattributed assignees, so every finding must trace to a verifiable source document.
Why do AI-generated patent landscapes often produce poor results?
The most common cause is retrieval failure rather than reasoning failure. When an AI system is pointed at an undifferentiated index rather than a curated corpus, it retrieves loosely related material and reasons over a diluted context. Scoping the corpus before retrieval reaches the model is what produces dense, high-signal output. Prompt refinement does not compensate for a corpus that does not contain the answer.
Does empty space on a patent map mean commercial opportunity?
No. Patent white space and commercial opportunity space are distinct concepts. An area with few patents may be sparse because the approach was attempted and failed, because competitors protect it through trade secrets, because the technology is not commercially viable, or because the regulatory pathway is closed. Distinguishing genuine opportunity from these alternatives requires scientific literature, regulatory records, and funding data alongside the patent record.
How often should a patent landscape analysis be updated?
Continuously, rather than on a fixed cycle. Global patent filings reached 3.7 million in 2025 and scientific publications passed 2 million articles, so a landscape begins degrading immediately after delivery. Once a corpus is curated and an agent is configured, the same configuration can evaluate new material as it publishes and surface only findings that meet defined escalation criteria, replacing periodic manual rebuilds with a maintained baseline.
Who should conduct a patent landscape analysis?
Corporate R&D directors, IP managers, innovation strategists, and technology scouting teams typically own landscape analysis, often in collaboration with internal IP counsel. The analysis supports research funding decisions, portfolio strategy, and partnership evaluation, so the owner should be close enough to those decisions to define the strategic question the analysis must answer.
What tools are used for patent landscape analysis?
Free resources including Google Patents, The Lens, and PQAI support verification and early scoping. Legacy professional platforms including Derwent Innovation and Orbit Intelligence provide curated patent data and advanced search built for IP prosecution and litigation workflows. Enterprise R&D intelligence platforms such as Cypris combine multi-dataset corpora with agentic execution and continuous monitoring, which is the tooling category aligned with the methodology described in this guide.

Michael Devon, a retired Research Fellow who spent 34 years at Dow tested three AI systems against complex, known-answer R&D scenarios. The largest performance gap appeared where technical depth, IP interpretation and roadmap development mattered most.
General-purpose AI tools such as Microsoft Copilot and Claude Opus 5 are built primarily around frontier foundation models and broad-access knowledge. Cypris can use the same class of foundation models, but grounds them in focused scientific and intellectual property datasets connected through domain-specific ontologies.
This comparison was designed to test whether that additional intelligence layer materially changes the quality of technical research.
Michael Devon, a retired Research Fellow who spent 34 years at Dow, evaluated Cypris, Microsoft Copilot and Claude Opus 5 across two technical scenarios and four prompts. He deliberately chose areas he knew intimately, allowing him to distinguish a plausible summary from an analysis that captured the technical realities, historical context and commercial considerations required to build an R&D strategy.
The scenarios were representative of projects that historically required weeks of coordinated researcher effort. The objective was not simply to determine which tool could find relevant information. It was to determine which could transform that information into useful technical and strategic guidance rooted in real world context.
Evaluation design
The comparison covered two technology landscapes: hollow latex particle opacifiers and the use of hydroxypropyl methylcellulose, or HPMC, in osmotic drug-delivery systems. The outputs were evaluated based on result quality, strategic insight, accuracy and the ability to recognize the boundaries between related technologies.

The hollow particle prompts asked the systems to map the competitive and IP landscape, identify emerging participants in Mexico and Asia, detect licensing or corporate activity and locate white space. They were then asked to recommend alternative materials, particle architectures and manufacturing mechanisms that could support a defensible product strategy.
The osmotic delivery prompts asked the systems to identify manufacturers and marketed products, followed by an analysis of HPMC grades, viscosity specifications, processing methods, prior art and potential formulation strategies.
Where the tools diverged
All three tools were capable of producing a credible general summary. The meaningful differences appeared as the work moved from describing the landscape to deciding what to do next.

Devon found that Cypris produced the strongest overall result, with the clearest advantage in the more technically and strategically complex hollow particle scenario. Claude and Copilot generally summarized what had been published. Cypris more frequently identified the specific technical issues, changes in IP ownership, commercial signals and research directions that could influence an actual development program.
Comparative findings at a glance


These distinctions were particularly visible in Devon's analysis of technical implementation, IP transfers, market context and research direction.
Scenario One: Hollow Latex Particle Opacifiers
All three tools passed the baseline test
Each system produced a reasonable summary of the general hollow particle landscape. Devon found no serious factual errors within the information each tool chose to present.
That baseline performance was important, but it did not determine the outcome. The systems differed substantially in the usefulness of their output for technical strategy development, with Cypris holding the clear advantage.
Cypris identified the technical issue most likely to derail a new entrant
One of the most consequential differences involved particle collapse.
Cypris recognized that maintaining particle structure was a central technical challenge and produced a useful explanation of the issue. Claude and Copilot did not identify its importance.
For a researcher, this was not a minor omission. A new entrant that fails to understand or overcome particle collapse could invest considerable time and capital in a manufacturing approach that does not perform under practical conditions. By surfacing the issue, Cypris provided information that could directly alter experimental priorities and development sequencing.
Cypris was not flawless. It did not fully distinguish between Dow's hollow latex work using caustic expansion and a separate abandoned macroporous latex approach. However, Claude and Copilot missed the macroporous work entirely.
The distinction illustrates the difference between partial technical interpretation and simple omission. Cypris found the relevant body of work but needed greater precision in separating the approaches. The general AI tools failed to surface the alternative development path at all.
Cypris produced a stronger picture of the IP landscape
Patent landscapes are often presented as lists of companies, filings and portfolio sizes. For technology strategy, that is rarely sufficient.
Researchers need to understand whether patents remain active and relevant, whether they have been transferred, whether the underlying technology is commercially practiced and whether a seemingly large portfolio contains meaningful gaps.
Claude and Copilot missed technology transfers between companies. Devon also found that Claude failed to recognize that significant portions of the IP landscape had changed hands or become outdated. These omissions can distort the competitive picture by assigning technology to the wrong owner or treating historically important patents as if they still define the current opportunity.
Cypris provided a more useful view of how the IP was structured and where potential white space existed. This helped move the analysis beyond a patent count and toward questions such as:
- Who currently controls the relevant technology?
- Which patents still create meaningful barriers?
- Where has ownership changed?
- Which approaches appear abandoned or underdeveloped?
- Where could a new entrant build, partner or acquire?
Devon noted that all three tools could be improved by incorporating deeper patent-office and file-wrapper information, maintenance status, litigation history and citation patterns. Those signals help determine whether a portfolio is genuinely defensible or simply appears strong based on volume.
Cypris surfaced technical and commercial concepts the others missed
Cypris was the only tool to identify the use of hollow particles in thermal printing. It also suggested additional markets and alternative applications.
That finding demonstrated a broader advantage in state-of-the-art analysis. Cypris did not restrict the output to the most obvious use of hollow particles as opacifiers. It connected the underlying technology to another commercially relevant application that Claude and Copilot failed to identify.
The distinction matters because technical strategy requires answering two different questions:
- Can the organization develop the technology?
- Is the opportunity commercially worth pursuing?
Claude and Copilot largely addressed the first question through general technical summaries. Cypris brought in more of the information required to begin addressing the second.
Some commercial outputs still required scrutiny. Devon considered Cypris' estimated 10 percent compound annual growth rate for the broader hollow particle market questionable, although its approximately 5 percent estimate for the thermal-printing segment appeared reasonable. The advantage was not that every market figure was definitive. It was that Cypris recognized adjacent commercial applications and incorporated them into the strategic analysis at all.
Cypris produced more useful white-space and roadmap recommendations
Both Cypris and Claude suggested alternatives to conventional latex-based particle systems. Copilot's recommendations were less insightful.
The quality of the alternatives, however, was different. Claude's output was more general and matter-of-fact. It identified possible approaches but did not translate them into strong white-space guidance.
Cypris proposed more technically credible alternatives and connected them more directly to a differentiated development strategy. Its roadmap recommendations were clearer about which directions merited further investigation and how the research could be sequenced.
The alternatives included non-latex and ceramic-based particle systems. The evaluation did not establish that every proposed direction was commercially viable, but Devon knew that some ceramic particles had progressed at least as far as commercial trials. Cypris therefore surfaced technically relevant research leads rather than merely generating hypothetical possibilities.
Specific findings that changed the strategic value of the output

Scenario Two: HPMC in Osmotic Drug Delivery
The baseline outputs were more similar
The osmotic drug-delivery scenario produced less separation between the three systems.
All three generated credible summaries of osmotic pump technology and identified, to varying degrees, the grades and functions of HPMC in the existing landscape. Devon found relatively little to distinguish the tools on the initial market, manufacturer and prior-art questions.
The systems also converged on a similar roadmap recommendation: use a Design of Experiments process to optimize HPMC for the different roles it plays in the formulation.
While technically valid, Devon considered that recommendation underwhelming. It represented a standard development methodology rather than a differentiated technical insight.
Cypris generated the most promising next research direction
The difference appeared when Cypris suggested a possible connection between osmotic delivery and the challenge of formulating poorly soluble drugs.
Many active pharmaceutical ingredients have limited aqueous solubility, creating substantial formulation and absorption challenges. Cypris' analysis pointed toward a possible connection with hydroxypropyl methylcellulose acetate succinate, or HPMCAS, a material used in approaches for poorly soluble drugs.
HPMCAS is distinct from the HPMC traditionally used in osmotic systems, and Cypris did not present the connection as a validated solution. Instead, it surfaced a cross-domain clue that an experienced researcher could recognize and investigate further.
Devon viewed this as a meaningful example of how technical research often progresses. The first search does not always deliver the final answer. A strong research system should also reveal the next productive question.
Cypris did that more effectively. It connected information from an adjacent technical area to the osmotic formulation problem, creating the basis for a more differentiated next prompt and potential research direction.
The Core Finding: Technical Intelligence Begins Where the Summary Ends
The comparison showed that general-purpose AI tools can produce useful technical summaries. Both Claude Opus 5 and Microsoft Copilot identified relevant companies, scientific concepts and prior art across the two scenarios.
Cypris separated itself in the work that followed:
- Recognizing a technical failure mode that could derail a development program
- Identifying ownership changes and outdated IP that altered the competitive landscape
- Finding adjacent applications such as thermal printing
- Producing more specific white-space guidance
- Connecting evidence to a clearer R&D roadmap
- Generating cross-domain clues that informed the next research question
This distinction reflects the role of the intelligence layer surrounding the foundation model. A general-purpose model is optimized to explain the available information coherently. A technical intelligence system must also organize patents, scientific literature, companies, materials and market signals into a structure that supports decisions.
Final assessment
Across the four prompts, Cypris produced the strongest overall performance.
The advantage was clearest in the hollow particle scenario, where Cypris demonstrated superior technical analysis, stronger IP intelligence, more credible white-space identification and more actionable roadmap recommendations. Claude Opus 5 was capable of producing credible summaries and some alternative ideas, but remained more general and missed important IP changes and white-space implications. Microsoft Copilot met the baseline requirement for landscape summarization but provided the least differentiated strategic guidance.
The osmotic delivery scenario was more competitive, but Cypris still produced the most promising next research direction by connecting the problem to an adjacent material and formulation challenge.
The conclusion was not simply that Cypris found more information. It more consistently identified the information that mattered.
For an experienced technical leader, that is the difference between receiving a summary of the landscape and receiving the raw material required to build a technology strategy.
